{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:39:41Z","timestamp":1772753981134,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/chromsci\/bmy114","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T20:14:09Z","timestamp":1545682449000},"page":"323-330","source":"Crossref","is-referenced-by-count":9,"title":["A Validated Ultra-Performance Liquid Chromatography Tandem Triple Quadrupole Mass Spectrometric Method for Fast Determination of Losartan in Rabbit Plasma"],"prefix":"10.1093","volume":"57","author":[{"given":"Mohd Aftab","family":"Alam","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh-11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuha Ibrahim","family":"Abou Obaid","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh-11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Abbas","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh-11451, Saudi Arabia"},{"name":"Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Raish","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh-11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad Ibrahim","family":"Al-Jenoobi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh-11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t2019032012171002500_bmy114C1","first-page":"211","article-title":"Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent","volume":"255","author":"Wong","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"key\n\t\t\t\t2019032012171002500_bmy114C2","first-page":"711","article-title":"Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent","volume":"252","author":"Chiu","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4 Pt 2","key":"key\n\t\t\t\t2019032012171002500_bmy114C3","doi-asserted-by":"crossref","first-page":"350S","DOI":"10.1093\/ajh\/4.4.350S","article-title":"Dose-response relationships following oral administration of DuP 753 to normal humans","volume":"4","author":"Christen","year":"1991","journal-title":"American Journal of Hypertension"},{"key":"key\n\t\t\t\t2019032012171002500_bmy114C4","author":"COZAAR\u00ae","year":"2017"},{"issue":"1","key":"key\n\t\t\t\t2019032012171002500_bmy114C5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0250-474X.62239","article-title":"Spectrophotometric and HPLC methods for simultaneous estimation of amlodipine besilate, losartan potassium and hydrochlorothiazide in tablets","volume":"72","author":"Wankhede","year":"2010","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"issue":"1","key":"key\n\t\t\t\t2019032012171002500_bmy114C6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0731-7085(00)00268-5","article-title":"Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography","volume":"23","author":"Carlucci","year":"2000","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"11","key":"key\n\t\t\t\t2019032012171002500_bmy114C7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/0731-7085(96)01740-2","article-title":"Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar tablets","volume":"14","author":"Williams","year":"1996","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"6","key":"key\n\t\t\t\t2019032012171002500_bmy114C8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/jaoac\/84.6.1715","article-title":"Simultaneous determination of losartan and hydrochlorothiazide in combined dosage forms by first-derivative spectroscopy and high-performance thin-layer chromatography","volume":"84","author":"Shah","year":"2001","journal-title":"Journal of AOAC International"},{"issue":"6","key":"key\n\t\t\t\t2019032012171002500_bmy114C9","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00216-008-2172-z","article-title":"Simultaneous determination of hydrochlorothiazide and losartan potassium in tablets by high-performance low-pressure chromatography using a multi-syringe burette coupled to a monolithic column","volume":"391","author":"Obando","year":"2008","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"7","key":"key\n\t\t\t\t2019032012171002500_bmy114C10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0731-7085(96)01948-6","article-title":"An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection","volume":"15","author":"Ritter","year":"1997","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019032012171002500_bmy114C11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0378-4347(97)00489-1","article-title":"Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate","volume":"704","author":"Farthing","year":"1997","journal-title":"Journal of Chromatography B: Biomedical Sciences and Applications"},{"issue":"2","key":"key\n\t\t\t\t2019032012171002500_bmy114C12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpba.2009.04.015","article-title":"Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection","volume":"50","author":"del Rosario Brunetto","year":"2009","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"3","key":"key\n\t\t\t\t2019032012171002500_bmy114C13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jpba.2009.01.007","article-title":"Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standard","volume":"49","author":"Prasaja","year":"2009","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"9","key":"key\n\t\t\t\t2019032012171002500_bmy114C14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/chromsci\/bmv047","article-title":"Simultaneous determination and pharmacokinetics of metolazone, losartan and losartan carboxylic acid in rat plasma by HPLC-ESI-MS-MS","volume":"53","author":"Dubey","year":"2015","journal-title":"Journal of Chromatographic Science"},{"key":"key\n\t\t\t\t2019032012171002500_bmy114C15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jchromb.2017.06.029","article-title":"High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS\/MS","volume":"1060","author":"van der Nagel","year":"2017","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"2","key":"key\n\t\t\t\t2019032012171002500_bmy114C16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0378-4347(92)80132-A","article-title":"Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography","volume":"573","author":"Furtek","year":"1992","journal-title":"Journal of Chromatography"},{"issue":"1","key":"key\n\t\t\t\t2019032012171002500_bmy114C17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0731-7085(03)00348-0","article-title":"Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography\/tandem mass spectrometry","volume":"33","author":"Polinko","year":"2003","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019032012171002500_bmy114C18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(00)00453-1","article-title":"Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection","volume":"204","author":"Yeung","year":"2000","journal-title":"International Journal of Pharmaceutics"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019032012171002500_bmy114C19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9673(01)01496-0","article-title":"Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection","volume":"949","author":"Gonz\u00e1lez","year":"2002","journal-title":"Journal of Chromatography A"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019032012171002500_bmy114C20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2005.09.015","article-title":"Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine","volume":"828","author":"Nie","year":"2005","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"5","key":"key\n\t\t\t\t2019032012171002500_bmy114C21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.448","article-title":"Comparative pharmacokinetics of two tablet formulations of Losartan: bioequivalence assessment","volume":"26","author":"Tamimi","year":"2005","journal-title":"Biopharmaceutics & Drug Disposition"},{"issue":"4","key":"key\n\t\t\t\t2019032012171002500_bmy114C22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF03189968","article-title":"Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report","volume":"16","author":"Shah","year":"1991","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"issue":"10","key":"key\n\t\t\t\t2019032012171002500_bmy114C23","first-page":"569","article-title":"A rapid HPLC method for the determination of losartan in human plasma using a monolithic column","volume":"55","author":"Zarghi","year":"2005","journal-title":"Arzneimittel-Forschung"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019032012171002500_bmy114C24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jchromb.2006.11.030","article-title":"Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhythmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design","volume":"850","author":"Kristoffersen","year":"2007","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"20","key":"key\n\t\t\t\t2019032012171002500_bmy114C25","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/jssc.200900287","article-title":"Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS\/MS","volume":"32","author":"Shah","year":"2009","journal-title":"Journal of Separation Science"},{"issue":"5","key":"key\n\t\t\t\t2019032012171002500_bmy114C26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10641960802668714","article-title":"Simultaneous determination of losartan and hydrochlorothiazide in human plasma by LC\/MS\/MS with electrospray ionization and its application to pharmacokinetics","volume":"31","author":"Salvadori","year":"2009","journal-title":"Clinical and Experimental Hypertension"},{"issue":"11","key":"key\n\t\t\t\t2019032012171002500_bmy114C27","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/bmc.1599","article-title":"High-performance liquid chromatographic determination of anti- hypertensive drugs on dried blood spots using a fluorescence detector\u2014method development and validation","volume":"25","author":"Rao","year":"2011","journal-title":"Biomedical Chromatography"},{"issue":"23","key":"key\n\t\t\t\t2019032012171002500_bmy114C28","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4155\/bio.12.261","article-title":"Analysis of losartan and carvedilol in urine and plasma samples using a dispersive liquid-liquid microextraction isocratic HPLC-UV method","volume":"4","author":"Soltani","year":"2012","journal-title":"Bioanalysis."},{"key":"key\n\t\t\t\t2019032012171002500_bmy114C29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jchromb.2013.05.027","article-title":"Ionic-liquid based dispersive liquid-liquid microextraction followed by high performance liquidchromatographic determination of anti-hypertensives in rat serum","volume":"931","author":"Rao","year":"2013","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"key\n\t\t\t\t2019032012171002500_bmy114C30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chroma.2016.02.004","article-title":"Application of modified stir bar with nickel:zinc sulphide nanoparticles loaded on activated carbon as a sorbent for preconcentration of losartan and valsartan and their determination by high performance liquid chromatography","volume":"1437","author":"Pebdani","year":"2016","journal-title":"Journal of Chromatography A"},{"key":"key\n\t\t\t\t2019032012171002500_bmy114C31","author":"Guidance for industry: Bioanalytical method validation","year":"2018"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/57\/4\/323\/28171098\/bmy114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T19:47:05Z","timestamp":1605815225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/57\/4\/323\/5298769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,1,22]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmy114","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,1,22]]}}}